Total and free IgE in evolution of severe asthma after omalizumab treatment

被引：0
|
作者：
Vennera, Maria del Carmen
Pascal, Mariona
Nunez, Ebymar Arismendi
Picado, Cesar
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Asthma; -; management; Treatments; Allergy;
D O I：
10.1183/13993003.congress-2016.PA4117
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4117
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The role of omalizumab in the treatment of adults with severe allergic asthma
    Kristan, Sabina Skrgat
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (03): : 142 - 149
  • [32] Severe Asthma - biological treatment with omalizumab - case report
    Osmenda, Grzegorz
    Jasiewicz-Honkisz, Barbara
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2016, 3 : S26 - S27
  • [33] Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE
    Lowe, Philip J.
    Renard, Didier
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (02) : 306 - 320
  • [34] Omalizumab (Xolair®) first anti-IgE antibody for treatment of poorly controlled severe persistent allergic asthma
    Pierre, Jacques
    PRESSE MEDICALE, 2007, 36 (03): : 444 - 444
  • [35] Analysis of asthma control and quality of life in severe allergic asthmatics under treatment with anti-IgE, omalizumab
    Pacheco-Galvan, Adalberto
    Hinojosa-Macias, Miguel
    Hurtado-Barbudo, Beatriz
    Gonzalez-Cervera, Jesus
    Sueiro-Bendito, Antonio
    MEDICINA CLINICA, 2009, 133 (12): : 460 - 463
  • [36] Serum IgE Levels as Predictor for Treatment Outcomes in Chinese Patients with Moderate or Severe Allergic Asthma Treated with Omalizumab
    Li, J.
    Kang, J.
    Wang, C.
    Yang, J.
    Lin, Z.
    Wang, S.
    Humphries, M.
    Kottakis, I.
    Fogel, R.
    Zhong, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] Free serum IgE concentration in severe persistent allergic asthma patients during omalizumab therapy. A preliminary study
    Zietkowski, Ziemowit
    Czarniakowska-Boltuc, Malgorzata
    Skiepko, Roman
    Lukaszyk, Mateusz
    Bodzenta-Lukaszyk, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2013, 18 (02): : 110 - 113
  • [38] Evaluation Of Omalizumab Efficiency After Sixteen To Twenty Weeks Of Treatment In Severe Persistant Asthma
    Mallet, A.
    Pacheco, Y.
    Freymond, N.
    Devouassoux, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [39] Omalizumab - An effective anti-IgE treatment for allergic asthma and rhinitis
    Casale, TB
    DRUGS OF TODAY, 2004, 40 (04) : 367 - 376
  • [40] Relapse Of Severe Asthma Exacerbations After Cessation Of Omalizumab Treatment - Real Life Data
    Kuprys-Lipinska, Izabela R.
    Kuna, Piotr
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB1 - AB1
12345